MCG
ABBV icon

McCollum Christoferson Group’s AbbVie ABBV Stock Holding History

McCollum Christoferson Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Buy
+850
New +$183K 0.06% 77
2026
Q1 		– Sell
-950
Closed -$217K – 78
2025
Q4 		$217K Hold
950
– – 0.06% 71
2025
Q3 		$220K Buy
+950
New +$193K 0.06% 70

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

McCollum Christoferson Group's ABBV Position: Q2 2026 in Review

McCollum Christoferson Group opened a new position in AbbVie (ABBV) in Q2 2026: 850 shares worth $214K. The stake represents 0.06% of the portfolio and ranks #77 among its holdings. This is a return to the name: McCollum Christoferson Group previously reported a position in ABBV as recently as Q4 2025.

McCollum Christoferson Group first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. The position peaked at $220K in Q3 2025. 2,136 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • McCollum Christoferson Group held 850 shares of AbbVie worth $214K as of Q2 2026.
  • AbbVie was a new McCollum Christoferson Group position in Q2 2026.
  • AbbVie made up 0.06% of McCollum Christoferson Group's portfolio in Q2 2026, its #77 holding.
  • McCollum Christoferson Group first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • McCollum Christoferson Group's AbbVie position peaked at $220K in Q3 2025.
  • 2,136 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on McCollum Christoferson Group's 13F filing for Q2 2026, filed 13 Jul 2026.